Cello Group plc (LON:CLL)‘s stock had its “buy” rating restated by equities research analysts at FinnCap in a research note issued to investors on Tuesday, StockTargetPrices.com reports. They presently have a GBX 132 ($1.72) price objective on the stock. FinnCap’s price target would suggest a potential upside of 23.94% from the stock’s previous close.

CLL has been the topic of a number of other research reports. Cenkos Securities Ltd reissued a “buy” rating on shares of Cello Group plc in a research report on Wednesday, September 14th. N+1 Singer reissued a “buy” rating on shares of Cello Group plc in a research report on Wednesday, September 14th. Finally, Peel Hunt reissued a “buy” rating on shares of Cello Group plc in a research report on Wednesday, July 13th. Five equities research analysts have rated the stock with a buy rating, Cello Group plc presently has a consensus rating of “Buy” and a consensus target price of GBX 123.75 ($1.62).

Analyst Recommendations for Cello Group plc (LON:CLL)

Cello Group plc (LON:CLL) traded down 1.39% during midday trading on Tuesday, reaching GBX 108.00. 33,449 shares of the company traded hands. Cello Group plc has a one year low of GBX 77.10 and a one year high of GBX 115.00. The stock’s market capitalization is GBX 93.77 billion. The company has a 50 day moving average price of GBX 106.36 and a 200-day moving average price of GBX 99.06.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/09/cello-group-plc-cll-receives-buy-rating-from-finncap.html

The company also recently declared a dividend, which will be paid on Friday, November 4th. Stockholders of record on Thursday, October 6th will be issued a GBX 1 ($0.01) dividend. This represents a dividend yield of 0.94%. The ex-dividend date is Thursday, October 6th.

About Cello Group plc

Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.

Stock Target Prices

Receive News & Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related companies with MarketBeat.com's FREE daily email newsletter.